Takeda to Buy Nycomed for $9.1 Billion to Fill Sales Gap

REPLAY VIDEO
Your next video will start in
Pause
  • Info

  • Comments

May 19 (Bloomberg) -- Takeda Pharmaceutical Co. agreed to buy closely held Nycomed for 6.3 billion euros ($9.1 billion) in the largest takeover by a Japanese drugmaker to cushion the blow of losing patent protection on its best-selling diabetes pill and expand in emerging markets. Shannon Pettypiece talks about the transaction and the outlook for Japanese drugmakers on Bloomberg Television's "In the Loop." (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change